|
|
 | | | |
- close
- close
- close
- close
Cardiovascular Systems (CSII) |
QUOTE AND NEWS
Benzinga
May 22
Comment
Cardiovascular Systems, Inc. (“CSI”) (Nasdaq: CSII), a medical device company focused on developing and commercializing innovative interventional treatment systems for vascular disease, today announced the pricing of an underwritten public...
Business Wire
May 2
Comment
Cardiovascular Systems, Inc. (Nasdaq: CSII): Revenues increased 8 percent over the second quarter of fiscal 2012, and 5 percent over the third quarter of fiscal 2011 to $21.2 million Stealth 360° revenues rose 24 percent over fiscal 2012 second
Business Wire
Apr 26
Comment
Cardiovascular Systems, Inc. (CSI) (Nasdaq: CSII) will host a live webcast of its fiscal 2012 third-quarter conference call on Wednesday, May 2, 2012, at 3:45 p.m. CT (4:45 p.m. ET). David L. Martin, president and chief executive officer, and
Benzinga
Apr 11
Comment
(c) 2011 Benzinga.com. All rights reserved. This material may not be published in its entirety or redistributed without the approval of Benzinga.
Business Wire
Mar 29
Comment
Cardiovascular Systems, Inc. (CSI) (Nasdaq: CSII), today announced results from a study of patients treated for peripheral arterial disease (PAD) with CSI’s Diamondback™ Orbital Atherectomy System in a non-hospital setting. Dr. Warren Swee, South
Benzinga
Mar 27
Comment
According to a research report published earlier today, Benchmark has initiated Cardiovascular Systems Inc. (NASDAQ: CSII) with a Speculative Buy rating and $15 PT.
In the report, Benchmark commented, “CSII's initial focus is on the treatment...
Wall Street Sector Selector
Jun 9
Comment
The market is still getting downside pressure, but we’re following stocks that still look pretty good. In fact, some are breaking out, and some are consolidating bullishly, so we’re going to take a look at a few of them.
Agilysys...
StreetInsider.com
Jun 6
Comment
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Cardiovascular+Systems+%28CSII%29+Updates+Study+Results+for+Diamondback+and+Predator+360+PAD+Systems/6563174.html for the full story.
StreetInsider.com
May 24
Comment
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Cardiovascular+Systems+%28CSII%29+Receives+FDA+Approval+to+Complete+ORBIT+II+Enrollment/6533112.html for the full story.
Benzinga
Apr 5
Comment
Acute data from Cardiovascular Systems' (Nasdaq: CSII) prospective, randomized COMPLIANCE 360° clinical trial was presented today at the American College of Cardiology's 60th Scientific Session in New Orleans. The study directly compared the...
Suggest other news sources for this topic
more ▼WIKI ANALYSIS
WIKI ANALYSIS
 |
The article on this company has not been written yet. If you're the first person to write this article, it's a sure thing that you'll be credited as a Top Contributor. For tips on getting started, check out the sample article. |
References
| |||||||
